Sponsored by

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 2126 to 2150 of about 5861

Previous 25

Website Changes

12/24/2013

Blaze Bioscience Announces Initiation of First-in-Human Phase 1 Clinical Study of BLZ-100 Tumor PaintTM technology enters clinical stage of development

12/24/2013

Added articles on: Dasatinib (Sprycel), Immunology and Virotherapy, and Supplements

12/22/2013

Two-drug combination slows malignant brain tumors in mice

12/19/2013

Added article: Social Security Disability and Brain Tumors

12/19/2013

Added article: Cancer and Evolution: Why chemotherapy fails

12/19/2013

Articles Added to the Clinical Trials and Noteworthy Treatments For Brain Tumors Website

12/19/2013

New Article: Electric Field Therapy and Photodynamic Therapy

12/19/2013

Added article: Targeting Tumor Metabolism

12/19/2013

Added article: Repurposed Drugs

12/18/2013

Positive Phase 2 Results from Agenus` Brain Cancer Vaccine Published in Neuro-Oncology

12/16/2013

IBTA Newsletter

12/15/2013

Centers for Medicare and Medicaid Services (CMS) Has Established Permanent Billing Codes for the NovoTTF-100A System™

12/15/2013

Novocure to Present Fifteen Abstracts Describing Latest Aspects of NovoTTF Therapy at the 4thQuadrennial Meeting of the World Federation of Neuro-Oncology (WFNO)

12/15/2013

ImmunoCellular Therapeutics Phase II Study Demonstrates That Glioblastoma Patients Live Longer Without Disease Progression When Treated With ICT-107

12/10/2013

Added the first in a hopefully large series of articles on brain tumors by Stephen Western. This first one is TARGETING TUMOR METABOLISM

12/05/2013

Study finds two distinct subtypes in pediatric diffuse intrinsic pontine gliomas

12/04/2013

S.D.-based Tocagen’s approach shrank tumors, improved function in trials

12/04/2013

Data Presented at Society for Neuro-Oncology Annual Meeting Demonstrate Tocagen`s Toca 511 Gene Therapy with Toca FC was Well Tolerated and Showed Antitumor Activity in Patients with High Grade Glioma

12/04/2013

Kinex Pharmaceuticals Announced that the U.S. Food and Drug Administration has Granted Orphan Drug Status to KX02 for the Treatment of Gliomas

12/04/2013

Mayo Clinic Researchers Find Shape-shifting Stops Migrating Cancer Cells

12/04/2013

Patients having brain cancer can improve their cognitive function by a new surgical approach

12/04/2013

Killer cocktail fights brain cancer

12/03/2013

Musella Foundation awards brain tumor research grant

11/30/2013

Scientists trumpet preclinical success of combo immunotherapy against brain cancer

11/29/2013

Medicare Open Enrollment October 15 - December 7, 2013

Our privacy / cookie policy has changed.
Click HERE to read it!